"The ophthalmologists & team at Florida Eye Microsurgical Institute put our patient’s needs as a top priority. With an expert team of highly-qualified, board certified physicians, nurses and technicians, our practice offers a comprehensive range of services to provide patients with routine eye care and exams, pediatric eye care, retinal care, corneal care and many other services and procedures. Located in Boynton Beach, Florida Eye is here to serve you and your family with any and all of your eye care and ophthalmology needs."

During the past decade, Florida Eye Microsurgical Institute conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 9 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 8 clinical trials were completed. i.e. 114.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Florida Eye Microsurgical Institute" #1 sponsor was "Kodiak Sciences Inc" with 4 trials, followed by "Apellis Pharmaceuticals, Inc." with 3 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored, "Genaera Corporation" with 2 trials sponsored and "Genentech, Inc." with 2 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Florida Eye Microsurgical Institute" #1 collaborator was "Bausch & Lomb Incorporated" with 1 trials as a collaborator, "Otsuka Pharmaceutical Co., Ltd." with 1 trials as a collaborator, "River Plate Biotechnology, Inc." with 1 trials as a collaborator and "Rx Development Resources, LLC" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Florida Eye Microsurgical Institute" are "Geographic Atrophy" (6 trials), "Macular Degeneration" (4 trials), "Dry Eye Disease" (3 trials), "Cataract" (2 trials) and "Keratoconjunctivitis Sicca" (2 trials). Many other conditions were trialed in "Florida Eye Microsurgical Institute" in a lesser frequency.

Most popular intervention types in "Florida Eye Microsurgical Institute" are "Drug" (26 trials), "Other" (9 trials), "Device" (3 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Sham Procedure" (6 trials), "Aflibercept" (4 trials), "KSI-301" (4 trials), "Lampalizumab" (3 trials) and "Sham" (2 trials). Other intervention names were less common.

The vast majority of trials in "Florida Eye Microsurgical Institute" are 30 trials for "All" genders.

Currently, there are NaN active trials in "Florida Eye Microsurgical Institute". undefined are not yet recruiting, 1 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Florida Eye Microsurgical Institute, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Florida Eye Microsurgical Institute, 1 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".